ARCHIVES

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Grants Awarded To Develop Special Populations Networks. AACR Honors Feinstein, Khayat.

April 14, 2000

Spiegelman Selected For BMS Award; Einstein Cancer Center Wins Grant.

July 4, 2003

FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.

March 31, 2000

Letter: Boy Has Little Chance At Cure Without Proven Treatments.

February 11, 2000

New Recommendations made For Radiation Protection Standards

August 14, 1987

Sole Source Negotiations

October 17, 1975